

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | viral transcription (GO:0019083) | 7.22173585 |
| 2 | translational termination (GO:0006415) | 7.03822993 |
| 3 | ribosomal small subunit biogenesis (GO:0042274) | 6.45666484 |
| 4 | translational elongation (GO:0006414) | 6.13246420 |
| 5 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 6.09794860 |
| 6 | ribosomal small subunit assembly (GO:0000028) | 6.09378432 |
| 7 | protein targeting to ER (GO:0045047) | 5.98341925 |
| 8 | cotranslational protein targeting to membrane (GO:0006613) | 5.96558922 |
| 9 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.72237808 |
| 10 | maturation of SSU-rRNA (GO:0030490) | 5.62925668 |
| 11 | translational initiation (GO:0006413) | 5.62639772 |
| 12 | protein localization to endoplasmic reticulum (GO:0070972) | 5.60597652 |
| 13 | viral life cycle (GO:0019058) | 5.46253432 |
| 14 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 5.45391226 |
| 15 | ribosomal large subunit biogenesis (GO:0042273) | 5.44288717 |
| 16 | cellular protein complex disassembly (GO:0043624) | 5.43284227 |
| 17 | formation of translation preinitiation complex (GO:0001731) | 4.68815834 |
| 18 | protein complex disassembly (GO:0043241) | 4.62407789 |
| 19 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.57314132 |
| 20 | translation (GO:0006412) | 4.49241829 |
| 21 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.41491065 |
| 22 | ATP synthesis coupled proton transport (GO:0015986) | 4.41491065 |
| 23 | macromolecular complex disassembly (GO:0032984) | 4.34854867 |
| 24 | ribonucleoprotein complex biogenesis (GO:0022613) | 4.27428299 |
| 25 | protein targeting to membrane (GO:0006612) | 4.08180566 |
| 26 | protein maturation by protein folding (GO:0022417) | 3.96249741 |
| 27 | regulation of translational fidelity (GO:0006450) | 3.93342694 |
| 28 | establishment of integrated proviral latency (GO:0075713) | 3.92714396 |
| 29 | DNA unwinding involved in DNA replication (GO:0006268) | 3.87233571 |
| 30 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.78151790 |
| 31 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.76203550 |
| 32 | * nucleobase-containing small molecule interconversion (GO:0015949) | 3.67282346 |
| 33 | mRNA catabolic process (GO:0006402) | 3.54689111 |
| 34 | ribosome assembly (GO:0042255) | 3.54520233 |
| 35 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.54225888 |
| 36 | proline biosynthetic process (GO:0006561) | 3.48771073 |
| 37 | rRNA processing (GO:0006364) | 3.39099161 |
| 38 | cellular component biogenesis (GO:0044085) | 3.34640818 |
| 39 | RNA catabolic process (GO:0006401) | 3.33686809 |
| 40 | nucleobase biosynthetic process (GO:0046112) | 3.31150770 |
| 41 | protein targeting to mitochondrion (GO:0006626) | 3.28810106 |
| 42 | purine nucleobase biosynthetic process (GO:0009113) | 3.28151300 |
| 43 | mitotic chromosome condensation (GO:0007076) | 3.25417981 |
| 44 | chaperone-mediated protein transport (GO:0072321) | 3.23566456 |
| 45 | rRNA metabolic process (GO:0016072) | 3.23502342 |
| 46 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.23145682 |
| 47 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.21853482 |
| 48 | respiratory electron transport chain (GO:0022904) | 3.21095593 |
| 49 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.15697738 |
| 50 | protein complex localization (GO:0031503) | 3.14852654 |
| 51 | electron transport chain (GO:0022900) | 3.13306534 |
| 52 | establishment of viral latency (GO:0019043) | 3.12781225 |
| 53 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.10368987 |
| 54 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.09584825 |
| 55 | ribosome biogenesis (GO:0042254) | 3.08234073 |
| 56 | regulation of translational termination (GO:0006449) | 3.06410433 |
| 57 | pseudouridine synthesis (GO:0001522) | 3.05063080 |
| 58 | heterochromatin organization (GO:0070828) | 3.04514745 |
| 59 | proteasome assembly (GO:0043248) | 3.01839924 |
| 60 | telomere maintenance via recombination (GO:0000722) | 3.00043585 |
| 61 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.99971298 |
| 62 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.98987124 |
| 63 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.98462076 |
| 64 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.98054875 |
| 65 | negative regulation of ligase activity (GO:0051352) | 2.98054875 |
| 66 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.97895415 |
| 67 | COPI coating of Golgi vesicle (GO:0048205) | 2.94795351 |
| 68 | Golgi transport vesicle coating (GO:0048200) | 2.94795351 |
| 69 | mitotic sister chromatid segregation (GO:0000070) | 2.94364964 |
| 70 | regulation of mitochondrial translation (GO:0070129) | 2.92682711 |
| 71 | folic acid metabolic process (GO:0046655) | 2.92547172 |
| 72 | DNA deamination (GO:0045006) | 2.92424683 |
| 73 | viral mRNA export from host cell nucleus (GO:0046784) | 2.91954120 |
| 74 | oxidative phosphorylation (GO:0006119) | 2.88627241 |
| 75 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.88063677 |
| 76 | protein localization to mitochondrion (GO:0070585) | 2.87499995 |
| 77 | termination of RNA polymerase III transcription (GO:0006386) | 2.86750207 |
| 78 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.86750207 |
| 79 | rRNA transcription (GO:0009303) | 2.85607499 |
| 80 | spliceosomal snRNP assembly (GO:0000387) | 2.82266727 |
| 81 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.81588334 |
| 82 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.81588334 |
| 83 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.80543984 |
| 84 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.80543984 |
| 85 | establishment of protein localization to membrane (GO:0090150) | 2.80259675 |
| 86 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.79445419 |
| 87 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.79386767 |
| 88 | mitotic recombination (GO:0006312) | 2.79054750 |
| 89 | histone arginine methylation (GO:0034969) | 2.78681419 |
| 90 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.77945033 |
| 91 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.77945033 |
| 92 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.77945033 |
| 93 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.77528075 |
| 94 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.77153815 |
| 95 | nuclear envelope reassembly (GO:0031468) | 2.75080036 |
| 96 | mitotic nuclear envelope reassembly (GO:0007084) | 2.75080036 |
| 97 | cellular protein complex localization (GO:0034629) | 2.74826357 |
| 98 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.74154942 |
| 99 | tRNA aminoacylation for protein translation (GO:0006418) | 2.73361496 |
| 100 | GDP-mannose metabolic process (GO:0019673) | 2.73168333 |
| 101 | glycine metabolic process (GO:0006544) | 2.72282771 |
| 102 | mitotic metaphase plate congression (GO:0007080) | 2.71551824 |
| 103 | rRNA modification (GO:0000154) | 2.70988558 |
| 104 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.70952873 |
| 105 | regulation of gene silencing by miRNA (GO:0060964) | 2.70952873 |
| 106 | regulation of gene silencing by RNA (GO:0060966) | 2.70952873 |
| 107 | * pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.69110627 |
| 108 | termination of RNA polymerase I transcription (GO:0006363) | 2.67246985 |
| 109 | protein targeting (GO:0006605) | 2.67162131 |
| 110 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.64824700 |
| 111 | positive regulation of ligase activity (GO:0051351) | 2.64074441 |
| 112 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.62952920 |
| 113 | establishment of protein localization to organelle (GO:0072594) | 2.60915707 |
| 114 | transcription from RNA polymerase I promoter (GO:0006360) | 2.60228526 |
| 115 | DNA replication checkpoint (GO:0000076) | 2.51011750 |
| 116 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.48815048 |
| 117 | positive regulation of cell cycle arrest (GO:0071158) | 2.48739695 |
| 118 | ventricular cardiac muscle cell development (GO:0055015) | 2.48155902 |
| 119 | IMP biosynthetic process (GO:0006188) | 2.47253683 |
| 120 | DNA strand elongation (GO:0022616) | 2.46391549 |
| 121 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.45801082 |
| 122 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.43589987 |
| 123 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.43188252 |
| 124 | chaperone-mediated protein complex assembly (GO:0051131) | 2.41919799 |
| 125 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.41478940 |
| 126 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.41478940 |
| 127 | protein localization to kinetochore (GO:0034501) | 2.41060008 |
| 128 | DNA replication initiation (GO:0006270) | 2.40775754 |
| 129 | establishment of protein localization to mitochondrion (GO:0072655) | 2.40356254 |
| 130 | 7-methylguanosine mRNA capping (GO:0006370) | 2.40160061 |
| 131 | serine family amino acid biosynthetic process (GO:0009070) | 2.39948911 |
| 132 | cell cycle G1/S phase transition (GO:0044843) | 2.39919280 |
| 133 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.39919280 |
| 134 | L-serine metabolic process (GO:0006563) | 2.38820797 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.47764013 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.11952005 |
| 3 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.72424341 |
| 4 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 3.23295680 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.19182710 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.14328626 |
| 7 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.96086105 |
| 8 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.94653630 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.93689811 |
| 10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.92087861 |
| 11 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.79765596 |
| 12 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.77295967 |
| 13 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.70036001 |
| 14 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.46493331 |
| 15 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.35008906 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.29661719 |
| 17 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.28945378 |
| 18 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.27662581 |
| 19 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.25169770 |
| 20 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.18240407 |
| 21 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 2.17877791 |
| 22 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.15010335 |
| 23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.12413599 |
| 24 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.03569670 |
| 25 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.98441358 |
| 26 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.91500888 |
| 27 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.91135844 |
| 28 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.88825089 |
| 29 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.88394056 |
| 30 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.81105770 |
| 31 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.76220020 |
| 32 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.75622508 |
| 33 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.69762702 |
| 34 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.69343240 |
| 35 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.67756308 |
| 36 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.66985928 |
| 37 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.66690173 |
| 38 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.63785303 |
| 39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.59960286 |
| 40 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.59556833 |
| 41 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.58966609 |
| 42 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52446064 |
| 43 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.51677188 |
| 44 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.50087772 |
| 45 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.48200064 |
| 46 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.48078206 |
| 47 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.46420254 |
| 48 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.42620642 |
| 49 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.41470325 |
| 50 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.40557130 |
| 51 | MYC_22102868_ChIP-Seq_BL_Human | 1.40391875 |
| 52 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.39189155 |
| 53 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.39003793 |
| 54 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.38271383 |
| 55 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.38035941 |
| 56 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.37355202 |
| 57 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.35375491 |
| 58 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.35324986 |
| 59 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.33727010 |
| 60 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.33350167 |
| 61 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.33000044 |
| 62 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.32622094 |
| 63 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32577598 |
| 64 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.32439531 |
| 65 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.31120194 |
| 66 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.31047584 |
| 67 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.30330692 |
| 68 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.29763647 |
| 69 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.28767768 |
| 70 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.28767768 |
| 71 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.28767768 |
| 72 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25333967 |
| 73 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.24117046 |
| 74 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.23738511 |
| 75 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.23342322 |
| 76 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.22612801 |
| 77 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.22306366 |
| 78 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.21575693 |
| 79 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.21474162 |
| 80 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.21207563 |
| 81 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21003600 |
| 82 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.20344155 |
| 83 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.19020770 |
| 84 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.18795623 |
| 85 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.18663815 |
| 86 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.15198488 |
| 87 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.14508808 |
| 88 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.14460085 |
| 89 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.14235080 |
| 90 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.14166913 |
| 91 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.13200420 |
| 92 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.12346333 |
| 93 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.12047101 |
| 94 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.11080751 |
| 95 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10946687 |
| 96 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.09991699 |
| 97 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.09836386 |
| 98 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.09622585 |
| 99 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.09317004 |
| 100 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.09117356 |
| 101 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08766821 |
| 102 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.07144906 |
| 103 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.06200172 |
| 104 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.06002072 |
| 105 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.05493387 |
| 106 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.05307904 |
| 107 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03695578 |
| 108 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.03489117 |
| 109 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.03416404 |
| 110 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.00633650 |
| 111 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.99405178 |
| 112 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.98900126 |
| 113 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.97830691 |
| 114 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.97774968 |
| 115 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.97751945 |
| 116 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97705521 |
| 117 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.97427050 |
| 118 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.97309653 |
| 119 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.97197673 |
| 120 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.96421510 |
| 121 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.95704172 |
| 122 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.94966664 |
| 123 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91030595 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 3.44572745 |
| 2 | MP0003693_abnormal_embryo_hatching | 3.33331743 |
| 3 | MP0004957_abnormal_blastocyst_morpholog | 2.93478830 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 2.89129378 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 2.80409807 |
| 6 | MP0009379_abnormal_foot_pigmentation | 2.72682041 |
| 7 | MP0002877_abnormal_melanocyte_morpholog | 2.70183259 |
| 8 | MP0000750_abnormal_muscle_regeneration | 2.40226750 |
| 9 | MP0005275_abnormal_skin_tensile | 2.24510822 |
| 10 | MP0004084_abnormal_cardiac_muscle | 1.96612710 |
| 11 | MP0003077_abnormal_cell_cycle | 1.93058606 |
| 12 | MP0003186_abnormal_redox_activity | 1.91965678 |
| 13 | MP0010234_abnormal_vibrissa_follicle | 1.89883838 |
| 14 | MP0003111_abnormal_nucleus_morphology | 1.86190555 |
| 15 | MP0010352_gastrointestinal_tract_polyps | 1.83312865 |
| 16 | MP0008932_abnormal_embryonic_tissue | 1.82400560 |
| 17 | MP0004233_abnormal_muscle_weight | 1.76120412 |
| 18 | MP0005503_abnormal_tendon_morphology | 1.74065037 |
| 19 | MP0010030_abnormal_orbit_morphology | 1.64760912 |
| 20 | MP0003315_abnormal_perineum_morphology | 1.63911532 |
| 21 | MP0003567_abnormal_fetal_cardiomyocyte | 1.63697466 |
| 22 | MP0000678_abnormal_parathyroid_gland | 1.57595338 |
| 23 | MP0001730_embryonic_growth_arrest | 1.54370354 |
| 24 | MP0003646_muscle_fatigue | 1.54212106 |
| 25 | MP0005023_abnormal_wound_healing | 1.49213441 |
| 26 | MP0010094_abnormal_chromosome_stability | 1.48688231 |
| 27 | MP0003279_aneurysm | 1.48149577 |
| 28 | MP0005330_cardiomyopathy | 1.47565604 |
| 29 | MP0003941_abnormal_skin_development | 1.46183779 |
| 30 | MP0003718_maternal_effect | 1.43854527 |
| 31 | MP0003566_abnormal_cell_adhesion | 1.41936667 |
| 32 | MP0006036_abnormal_mitochondrial_physio | 1.39843858 |
| 33 | MP0003123_paternal_imprinting | 1.33647145 |
| 34 | MP0001542_abnormal_bone_strength | 1.33414460 |
| 35 | MP0004858_abnormal_nervous_system | 1.33402301 |
| 36 | MP0009672_abnormal_birth_weight | 1.31837814 |
| 37 | MP0005058_abnormal_lysosome_morphology | 1.31126690 |
| 38 | MP0000313_abnormal_cell_death | 1.30732814 |
| 39 | MP0008007_abnormal_cellular_replicative | 1.30616752 |
| 40 | MP0004185_abnormal_adipocyte_glucose | 1.28597372 |
| 41 | MP0004272_abnormal_basement_membrane | 1.27992578 |
| 42 | MP0001661_extended_life_span | 1.26656118 |
| 43 | MP0001849_ear_inflammation | 1.25902774 |
| 44 | MP0002837_dystrophic_cardiac_calcinosis | 1.24320611 |
| 45 | MP0001881_abnormal_mammary_gland | 1.23889872 |
| 46 | MP0009053_abnormal_anal_canal | 1.22698173 |
| 47 | MP0000350_abnormal_cell_proliferation | 1.20579807 |
| 48 | MP0000749_muscle_degeneration | 1.20065575 |
| 49 | MP0003221_abnormal_cardiomyocyte_apopto | 1.19633726 |
| 50 | MP0000490_abnormal_crypts_of | 1.16946627 |
| 51 | MP0001672_abnormal_embryogenesis/_devel | 1.16178410 |
| 52 | MP0005380_embryogenesis_phenotype | 1.16178410 |
| 53 | MP0005076_abnormal_cell_differentiation | 1.14125335 |
| 54 | MP0003984_embryonic_growth_retardation | 1.12443944 |
| 55 | MP0002088_abnormal_embryonic_growth/wei | 1.12173908 |
| 56 | MP0003786_premature_aging | 1.09957931 |
| 57 | * MP0001697_abnormal_embryo_size | 1.09887825 |
| 58 | MP0002163_abnormal_gland_morphology | 1.09809308 |
| 59 | MP0002060_abnormal_skin_morphology | 1.08005982 |
| 60 | MP0009840_abnormal_foam_cell | 1.07574636 |
| 61 | MP0005451_abnormal_body_composition | 1.06727778 |
| 62 | MP0009697_abnormal_copulation | 1.05300158 |
| 63 | MP0000358_abnormal_cell_content/ | 1.03621000 |
| 64 | MP0000627_abnormal_mammary_gland | 1.02749231 |
| 65 | MP0003828_pulmonary_edema | 1.02472987 |
| 66 | MP0002080_prenatal_lethality | 1.02335511 |
| 67 | MP0000579_abnormal_nail_morphology | 1.02229358 |
| 68 | MP0004197_abnormal_fetal_growth/weight/ | 1.01570022 |
| 69 | MP0002697_abnormal_eye_size | 1.00497120 |
| 70 | MP0004087_abnormal_muscle_fiber | 1.00417535 |
| 71 | MP0002796_impaired_skin_barrier | 1.00336241 |
| 72 | MP0001727_abnormal_embryo_implantation | 0.99341001 |
| 73 | MP0009333_abnormal_splenocyte_physiolog | 0.98915095 |
| 74 | MP0000751_myopathy | 0.98888124 |
| 75 | MP0005332_abnormal_amino_acid | 0.98244938 |
| 76 | MP0002249_abnormal_larynx_morphology | 0.97842610 |
| 77 | MP0000858_altered_metastatic_potential | 0.97767512 |
| 78 | MP0005385_cardiovascular_system_phenoty | 0.95712978 |
| 79 | MP0001544_abnormal_cardiovascular_syste | 0.95712978 |
| 80 | MP0003453_abnormal_keratinocyte_physiol | 0.95476396 |
| 81 | MP0004036_abnormal_muscle_relaxation | 0.93795212 |
| 82 | MP0002086_abnormal_extraembryonic_tissu | 0.93513071 |
| 83 | MP0010630_abnormal_cardiac_muscle | 0.93340855 |
| 84 | MP0005083_abnormal_biliary_tract | 0.92283529 |
| 85 | MP0003942_abnormal_urinary_system | 0.92170875 |
| 86 | MP0000733_abnormal_muscle_development | 0.91991458 |
| 87 | MP0005666_abnormal_adipose_tissue | 0.90841375 |
| 88 | MP0008260_abnormal_autophagy | 0.90540393 |
| 89 | MP0005360_urolithiasis | 0.90461996 |
| 90 | MP0002269_muscular_atrophy | 0.90258693 |
| 91 | MP0006035_abnormal_mitochondrial_morpho | 0.90084109 |
| 92 | MP0008775_abnormal_heart_ventricle | 0.89387460 |
| 93 | MP0009384_cardiac_valve_regurgitation | 0.89171547 |
| 94 | MP0002085_abnormal_embryonic_tissue | 0.88776170 |
| 95 | MP0001958_emphysema | 0.88369272 |
| 96 | MP0001346_abnormal_lacrimal_gland | 0.88173422 |
| 97 | MP0005408_hypopigmentation | 0.87663427 |
| 98 | MP0005501_abnormal_skin_physiology | 0.87316325 |
| 99 | MP0002160_abnormal_reproductive_system | 0.87088772 |
| 100 | MP0005508_abnormal_skeleton_morphology | 0.86746878 |
| 101 | MP0000343_altered_response_to | 0.85916397 |
| 102 | MP0000467_abnormal_esophagus_morphology | 0.85140990 |
| 103 | MP0001216_abnormal_epidermal_layer | 0.83548652 |
| 104 | MP0010771_integument_phenotype | 0.83111998 |
| 105 | MP0001243_abnormal_dermal_layer | 0.83067372 |
| 106 | MP0008057_abnormal_DNA_replication | 0.82540033 |
| 107 | MP0002938_white_spotting | 0.81992821 |
| 108 | MP0003937_abnormal_limbs/digits/tail_de | 0.80743180 |
| 109 | MP0006138_congestive_heart_failure | 0.80594998 |
| 110 | MP0004782_abnormal_surfactant_physiolog | 0.80447858 |
| 111 | MP0000747_muscle_weakness | 0.79375578 |
| 112 | MP0008058_abnormal_DNA_repair | 0.79187550 |
| 113 | MP0005623_abnormal_meninges_morphology | 0.78886010 |
| 114 | MP0000759_abnormal_skeletal_muscle | 0.78269639 |
| 115 | MP0003195_calcinosis | 0.77558793 |
| 116 | MP0002084_abnormal_developmental_patter | 0.77050228 |
| 117 | MP0005384_cellular_phenotype | 0.77028564 |
| 118 | MP0002106_abnormal_muscle_physiology | 0.76962013 |
| 119 | MP0009250_abnormal_appendicular_skeleto | 0.76892176 |
| 120 | MP0004264_abnormal_extraembryonic_tissu | 0.76799111 |
| 121 | MP0005257_abnormal_intraocular_pressure | 0.76785325 |
| 122 | MP0005220_abnormal_exocrine_pancreas | 0.75636379 |
| 123 | MP0000372_irregular_coat_pigmentation | 0.75522831 |
| 124 | MP0002111_abnormal_tail_morphology | 0.75193333 |
| 125 | MP0002332_abnormal_exercise_endurance | 0.74490971 |
| 126 | MP0002282_abnormal_trachea_morphology | 0.73892223 |
| 127 | MP0000049_abnormal_middle_ear | 0.73592567 |
| 128 | MP0010307_abnormal_tumor_latency | 0.72440588 |
| 129 | MP0005266_abnormal_metabolism | 0.72145384 |
| 130 | MP0005395_other_phenotype | 0.71950883 |
| 131 | MP0000003_abnormal_adipose_tissue | 0.71910722 |
| 132 | MP0000762_abnormal_tongue_morphology | 0.71666592 |
| 133 | MP0000462_abnormal_digestive_system | 0.70756451 |
| 134 | MP0000537_abnormal_urethra_morphology | 0.70262063 |
| 135 | MP0009643_abnormal_urine_homeostasis | 0.70178940 |
| 136 | MP0002295_abnormal_pulmonary_circulatio | 0.69980809 |
| 137 | MP0005621_abnormal_cell_physiology | 0.69198130 |
| 138 | MP0002972_abnormal_cardiac_muscle | 0.68276116 |
| 139 | MP0002019_abnormal_tumor_incidence | 0.67800610 |
| 140 | MP0002234_abnormal_pharynx_morphology | 0.67329292 |
| 141 | MP0002098_abnormal_vibrissa_morphology | 0.67243450 |
| 142 | MP0002092_abnormal_eye_morphology | 0.67032961 |
| 143 | MP0003385_abnormal_body_wall | 0.66256695 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.79363770 |
| 2 | Reticulocytopenia (HP:0001896) | 4.67226185 |
| 3 | Multiple enchondromatosis (HP:0005701) | 4.08243229 |
| 4 | Macrocytic anemia (HP:0001972) | 3.97171271 |
| 5 | Abnormal number of erythroid precursors (HP:0012131) | 3.88706303 |
| 6 | Protrusio acetabuli (HP:0003179) | 3.83844992 |
| 7 | Premature rupture of membranes (HP:0001788) | 3.83340129 |
| 8 | Acute necrotizing encephalopathy (HP:0006965) | 3.48369788 |
| 9 | Microvesicular hepatic steatosis (HP:0001414) | 3.31710321 |
| 10 | Abnormal hemoglobin (HP:0011902) | 3.29595020 |
| 11 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.14916651 |
| 12 | Acute encephalopathy (HP:0006846) | 3.07844933 |
| 13 | Pallor (HP:0000980) | 3.07665933 |
| 14 | Trismus (HP:0000211) | 3.05948420 |
| 15 | Cerebral edema (HP:0002181) | 2.87215718 |
| 16 | Carpal bone hypoplasia (HP:0001498) | 2.83799537 |
| 17 | Mitochondrial inheritance (HP:0001427) | 2.78979137 |
| 18 | Hepatic necrosis (HP:0002605) | 2.76509518 |
| 19 | Progressive macrocephaly (HP:0004481) | 2.70139981 |
| 20 | Increased connective tissue (HP:0009025) | 2.66680386 |
| 21 | Abnormal cartilage morphology (HP:0002763) | 2.65325609 |
| 22 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.63095372 |
| 23 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.63095372 |
| 24 | Increased CSF lactate (HP:0002490) | 2.62479500 |
| 25 | Breast hypoplasia (HP:0003187) | 2.61184893 |
| 26 | Muscle fiber splitting (HP:0003555) | 2.59506454 |
| 27 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.55198503 |
| 28 | Ragged-red muscle fibers (HP:0003200) | 2.47803366 |
| 29 | Rhabdomyolysis (HP:0003201) | 2.42248012 |
| 30 | Hepatocellular necrosis (HP:0001404) | 2.41526210 |
| 31 | Abnormality of glycolysis (HP:0004366) | 2.39874540 |
| 32 | Increased serum pyruvate (HP:0003542) | 2.39874540 |
| 33 | Congenital, generalized hypertrichosis (HP:0004540) | 2.37602311 |
| 34 | Abnormality of the umbilical cord (HP:0010881) | 2.37052724 |
| 35 | Ankle contracture (HP:0006466) | 2.36119656 |
| 36 | Ventricular tachycardia (HP:0004756) | 2.35295739 |
| 37 | Lipid accumulation in hepatocytes (HP:0006561) | 2.34459437 |
| 38 | Septate vagina (HP:0001153) | 2.31860573 |
| 39 | Chromsome breakage (HP:0040012) | 2.30559283 |
| 40 | Nausea (HP:0002018) | 2.29066231 |
| 41 | Increased hepatocellular lipid droplets (HP:0006565) | 2.27274338 |
| 42 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.23203319 |
| 43 | Type I transferrin isoform profile (HP:0003642) | 2.22718172 |
| 44 | Hyperglycinuria (HP:0003108) | 2.21504469 |
| 45 | Rough bone trabeculation (HP:0100670) | 2.20660184 |
| 46 | Respiratory failure (HP:0002878) | 2.20144650 |
| 47 | Exercise intolerance (HP:0003546) | 2.18645340 |
| 48 | Renal Fanconi syndrome (HP:0001994) | 2.17954749 |
| 49 | Reduced antithrombin III activity (HP:0001976) | 2.17202532 |
| 50 | Achilles tendon contracture (HP:0001771) | 2.16023908 |
| 51 | Difficulty climbing stairs (HP:0003551) | 2.15141449 |
| 52 | Hyperacusis (HP:0010780) | 2.15047334 |
| 53 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.14200486 |
| 54 | Soft skin (HP:0000977) | 2.12866263 |
| 55 | Progressive muscle weakness (HP:0003323) | 2.12713722 |
| 56 | Facial cleft (HP:0002006) | 2.12228022 |
| 57 | Glossoptosis (HP:0000162) | 2.11330936 |
| 58 | Abnormal trabecular bone morphology (HP:0100671) | 2.10922925 |
| 59 | Testicular atrophy (HP:0000029) | 2.08413057 |
| 60 | Vertebral compression fractures (HP:0002953) | 2.07210039 |
| 61 | Spinal cord compression (HP:0002176) | 2.06026829 |
| 62 | Respiratory difficulties (HP:0002880) | 2.05987081 |
| 63 | Aplastic anemia (HP:0001915) | 2.05672846 |
| 64 | Broad distal phalanx of finger (HP:0009836) | 2.05655546 |
| 65 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.03684456 |
| 66 | Dicarboxylic aciduria (HP:0003215) | 2.03684456 |
| 67 | Abnormal gallbladder physiology (HP:0012438) | 2.02613395 |
| 68 | Cholecystitis (HP:0001082) | 2.02613395 |
| 69 | Hyperglycinemia (HP:0002154) | 2.01757709 |
| 70 | Lethargy (HP:0001254) | 2.01665653 |
| 71 | Biconcave vertebral bodies (HP:0004586) | 1.98926062 |
| 72 | Lactic acidosis (HP:0003128) | 1.98170251 |
| 73 | Selective tooth agenesis (HP:0001592) | 1.96720537 |
| 74 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.95855307 |
| 75 | Abnormality of glycine metabolism (HP:0010895) | 1.95855307 |
| 76 | Abnormality of reticulocytes (HP:0004312) | 1.94392707 |
| 77 | Oral leukoplakia (HP:0002745) | 1.94333258 |
| 78 | Increased serum lactate (HP:0002151) | 1.93598781 |
| 79 | Distal lower limb muscle weakness (HP:0009053) | 1.92343674 |
| 80 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.90339439 |
| 81 | Single umbilical artery (HP:0001195) | 1.90339439 |
| 82 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.90339439 |
| 83 | Exercise-induced muscle cramps (HP:0003710) | 1.89378719 |
| 84 | Peritonitis (HP:0002586) | 1.89150026 |
| 85 | Microglossia (HP:0000171) | 1.87421804 |
| 86 | Abnormality of the Achilles tendon (HP:0005109) | 1.87035423 |
| 87 | Cervical subluxation (HP:0003308) | 1.86848417 |
| 88 | Increased intramyocellular lipid droplets (HP:0012240) | 1.86363495 |
| 89 | Increased muscle lipid content (HP:0009058) | 1.85634794 |
| 90 | Spinal rigidity (HP:0003306) | 1.85596201 |
| 91 | Degeneration of anterior horn cells (HP:0002398) | 1.85341480 |
| 92 | Abnormality of the anterior horn cell (HP:0006802) | 1.85341480 |
| 93 | Redundant skin (HP:0001582) | 1.85004794 |
| 94 | Squamous cell carcinoma (HP:0002860) | 1.84941613 |
| 95 | Hypoglycemic coma (HP:0001325) | 1.84422660 |
| 96 | Asymmetry of the thorax (HP:0001555) | 1.84182869 |
| 97 | Progressive external ophthalmoplegia (HP:0000590) | 1.84119906 |
| 98 | Generalized amyotrophy (HP:0003700) | 1.83984343 |
| 99 | Right ventricular cardiomyopathy (HP:0011663) | 1.83564987 |
| 100 | Deviation of the thumb (HP:0009603) | 1.83294865 |
| 101 | Conjunctival hamartoma (HP:0100780) | 1.83228897 |
| 102 | Lipoatrophy (HP:0100578) | 1.82829748 |
| 103 | Hypokinesia (HP:0002375) | 1.81145913 |
| 104 | Gout (HP:0001997) | 1.81138242 |
| 105 | Colon cancer (HP:0003003) | 1.80511819 |
| 106 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.79961328 |
| 107 | Secondary amenorrhea (HP:0000869) | 1.79589918 |
| 108 | Birth length less than 3rd percentile (HP:0003561) | 1.79308642 |
| 109 | Proximal placement of thumb (HP:0009623) | 1.79167412 |
| 110 | Elbow flexion contracture (HP:0002987) | 1.78191588 |
| 111 | Abnormality of the preputium (HP:0100587) | 1.77762936 |
| 112 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.74740597 |
| 113 | Microretrognathia (HP:0000308) | 1.74418890 |
| 114 | Generalized aminoaciduria (HP:0002909) | 1.74292878 |
| 115 | Insomnia (HP:0100785) | 1.74078815 |
| 116 | Abnormality of serum amino acid levels (HP:0003112) | 1.74022344 |
| 117 | Myoglobinuria (HP:0002913) | 1.73624032 |
| 118 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.72366631 |
| 119 | Type 1 muscle fiber predominance (HP:0003803) | 1.71776690 |
| 120 | CNS demyelination (HP:0007305) | 1.71123892 |
| 121 | Beaking of vertebral bodies (HP:0004568) | 1.69643679 |
| 122 | Pancytopenia (HP:0001876) | 1.69486547 |
| 123 | Metaphyseal cupping (HP:0003021) | 1.68843293 |
| 124 | Exertional dyspnea (HP:0002875) | 1.68448132 |
| 125 | Sparse eyelashes (HP:0000653) | 1.68357475 |
| 126 | Calcaneovalgus deformity (HP:0001848) | 1.68328821 |
| 127 | Stenosis of the external auditory canal (HP:0000402) | 1.68302369 |
| 128 | Cleft eyelid (HP:0000625) | 1.67972022 |
| 129 | Abnormality of dentin (HP:0010299) | 1.67731252 |
| 130 | Adenoma sebaceum (HP:0009720) | 1.67586288 |
| 131 | Angiofibromas (HP:0010615) | 1.67586288 |
| 132 | Atresia of the external auditory canal (HP:0000413) | 1.66439148 |
| 133 | Abnormal number of incisors (HP:0011064) | 1.65994123 |
| 134 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.65862127 |
| 135 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.65862127 |
| 136 | Abnormal protein glycosylation (HP:0012346) | 1.65862127 |
| 137 | Abnormal glycosylation (HP:0012345) | 1.65862127 |
| 138 | Fused cervical vertebrae (HP:0002949) | 1.65777629 |
| 139 | Ureteral duplication (HP:0000073) | 1.65325106 |
| 140 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.65206879 |
| 141 | Osteolytic defects of the hand bones (HP:0009699) | 1.65206879 |
| 142 | Sudden death (HP:0001699) | 1.64911053 |
| 143 | Patent foramen ovale (HP:0001655) | 1.64851693 |
| 144 | Fasciculations (HP:0002380) | 1.64565117 |
| 145 | Palpitations (HP:0001962) | 1.64024553 |
| 146 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.63894744 |
| 147 | Ulnar bowing (HP:0003031) | 1.63859744 |
| 148 | Nasolacrimal duct obstruction (HP:0000579) | 1.62326596 |
| 149 | Short nail (HP:0001799) | 1.61823955 |
| 150 | Sensory axonal neuropathy (HP:0003390) | 1.61490820 |
| 151 | Delayed cranial suture closure (HP:0000270) | 1.61449500 |
| 152 | Premature ovarian failure (HP:0008209) | 1.60338752 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 3.81315277 |
| 2 | BUB1 | 3.79092519 |
| 3 | WEE1 | 3.18148572 |
| 4 | SMG1 | 3.03281326 |
| 5 | IRAK3 | 2.71567743 |
| 6 | BCKDK | 2.54616986 |
| 7 | TTN | 2.48857829 |
| 8 | EIF2AK1 | 2.40330961 |
| 9 | EPHA2 | 2.39137146 |
| 10 | PIM2 | 2.22697191 |
| 11 | NEK1 | 1.97770667 |
| 12 | TLK1 | 1.93150186 |
| 13 | PKN2 | 1.90602742 |
| 14 | LATS2 | 1.85349325 |
| 15 | TRIB3 | 1.85325020 |
| 16 | RPS6KB2 | 1.75917842 |
| 17 | EIF2AK3 | 1.72103340 |
| 18 | LRRK2 | 1.70979361 |
| 19 | RPS6KA4 | 1.69248472 |
| 20 | SRPK1 | 1.68062735 |
| 21 | MAP3K3 | 1.65964276 |
| 22 | TESK2 | 1.64011195 |
| 23 | NME1 | 1.53540542 |
| 24 | STK38L | 1.48148021 |
| 25 | ILK | 1.47964012 |
| 26 | NEK2 | 1.43856501 |
| 27 | TTK | 1.40075921 |
| 28 | AURKB | 1.39522366 |
| 29 | BRSK2 | 1.38026574 |
| 30 | PBK | 1.35183573 |
| 31 | ICK | 1.34830726 |
| 32 | PAK4 | 1.32547232 |
| 33 | TESK1 | 1.31488796 |
| 34 | LIMK1 | 1.31162603 |
| 35 | BRSK1 | 1.29047285 |
| 36 | SIK1 | 1.27366738 |
| 37 | MAP3K8 | 1.26711275 |
| 38 | PLK1 | 1.25581919 |
| 39 | MAP2K3 | 1.24269562 |
| 40 | NEK9 | 1.21599762 |
| 41 | CDC7 | 1.21563175 |
| 42 | ERN1 | 1.20654482 |
| 43 | CDK8 | 1.20617544 |
| 44 | TGFBR1 | 1.17698556 |
| 45 | ABL2 | 1.16707001 |
| 46 | PASK | 1.16573292 |
| 47 | PDK3 | 1.16024654 |
| 48 | PDK4 | 1.16024654 |
| 49 | MAPKAPK3 | 1.15261707 |
| 50 | DYRK3 | 1.14799347 |
| 51 | MST1R | 1.14760729 |
| 52 | MYLK | 1.12293408 |
| 53 | MAP3K11 | 1.11446310 |
| 54 | AURKA | 1.11213744 |
| 55 | CDK7 | 1.10921266 |
| 56 | MET | 1.09890606 |
| 57 | KDR | 1.09534605 |
| 58 | ARAF | 1.09404367 |
| 59 | ZAK | 1.06864039 |
| 60 | TSSK6 | 1.04598692 |
| 61 | PDK2 | 1.04094572 |
| 62 | DDR2 | 1.04030080 |
| 63 | TAF1 | 0.98874525 |
| 64 | BRAF | 0.98848666 |
| 65 | OBSCN | 0.97582667 |
| 66 | FLT3 | 0.95306294 |
| 67 | STK16 | 0.95153279 |
| 68 | PAK1 | 0.92524928 |
| 69 | VRK1 | 0.91560653 |
| 70 | PLK4 | 0.89527987 |
| 71 | MAP2K2 | 0.88739187 |
| 72 | PAK2 | 0.88000002 |
| 73 | DAPK1 | 0.87647737 |
| 74 | MST4 | 0.87044521 |
| 75 | EPHB2 | 0.84447557 |
| 76 | DAPK3 | 0.84426253 |
| 77 | PTK2 | 0.82302471 |
| 78 | ACVR1B | 0.81854233 |
| 79 | CDK4 | 0.81727704 |
| 80 | STK4 | 0.80313673 |
| 81 | LATS1 | 0.79088328 |
| 82 | STK3 | 0.77626876 |
| 83 | MAP3K12 | 0.77447551 |
| 84 | PLK3 | 0.77406271 |
| 85 | PIM1 | 0.75412870 |
| 86 | MOS | 0.70984281 |
| 87 | * NME2 | 0.69701841 |
| 88 | MKNK1 | 0.68887356 |
| 89 | STK10 | 0.67003610 |
| 90 | CSNK2A2 | 0.65616898 |
| 91 | ERBB4 | 0.64901262 |
| 92 | RPS6KA5 | 0.64049028 |
| 93 | CSNK2A1 | 0.60323657 |
| 94 | PRKCI | 0.59633394 |
| 95 | CHEK2 | 0.59242134 |
| 96 | TAOK2 | 0.58952040 |
| 97 | PRKD3 | 0.56435836 |
| 98 | IRAK2 | 0.56117047 |
| 99 | EEF2K | 0.55890925 |
| 100 | CDK6 | 0.53039962 |
| 101 | ALK | 0.53034112 |
| 102 | PRPF4B | 0.52270952 |
| 103 | PIK3CG | 0.51875459 |
| 104 | CDK12 | 0.51557901 |
| 105 | MUSK | 0.51465096 |
| 106 | EIF2AK2 | 0.50464184 |
| 107 | LMTK2 | 0.50110269 |
| 108 | MARK3 | 0.49369295 |
| 109 | STK24 | 0.46684485 |
| 110 | SCYL2 | 0.46198192 |
| 111 | AKT2 | 0.45799381 |
| 112 | TRPM7 | 0.44357602 |
| 113 | BMX | 0.44217792 |
| 114 | DYRK2 | 0.42474767 |
| 115 | MTOR | 0.41872975 |
| 116 | PTK6 | 0.41439956 |
| 117 | CSNK1G3 | 0.41257350 |
| 118 | CDK2 | 0.40888540 |
| 119 | MAP3K10 | 0.39641339 |
| 120 | CHEK1 | 0.39314879 |
| 121 | * CDK1 | 0.39006681 |
| 122 | MAP3K9 | 0.36959996 |
| 123 | CAMK2G | 0.36076523 |
| 124 | PDGFRA | 0.35962589 |
| 125 | ATR | 0.35829386 |
| 126 | MAP3K5 | 0.35661269 |
| 127 | PRKG2 | 0.35372078 |
| 128 | CDK11A | 0.33622590 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.66564023 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.66740673 |
| 3 | RNA polymerase_Homo sapiens_hsa03020 | 2.91060897 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.72905875 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 2.58746640 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.55029588 |
| 7 | DNA replication_Homo sapiens_hsa03030 | 2.36071161 |
| 8 | RNA transport_Homo sapiens_hsa03013 | 2.01171058 |
| 9 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.97378700 |
| 10 | Mismatch repair_Homo sapiens_hsa03430 | 1.96234815 |
| 11 | Huntingtons disease_Homo sapiens_hsa05016 | 1.91995279 |
| 12 | Spliceosome_Homo sapiens_hsa03040 | 1.88243831 |
| 13 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.87811158 |
| 14 | * Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.82881496 |
| 15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.77028553 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.72372066 |
| 17 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.71091725 |
| 18 | Protein export_Homo sapiens_hsa03060 | 1.61726344 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.59526438 |
| 20 | Alzheimers disease_Homo sapiens_hsa05010 | 1.58268578 |
| 21 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.53781787 |
| 22 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.51250356 |
| 23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.46022173 |
| 24 | Carbon metabolism_Homo sapiens_hsa01200 | 1.40124884 |
| 25 | Homologous recombination_Homo sapiens_hsa03440 | 1.39832392 |
| 26 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.39213170 |
| 27 | Base excision repair_Homo sapiens_hsa03410 | 1.32555052 |
| 28 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.31582846 |
| 29 | Sulfur relay system_Homo sapiens_hsa04122 | 1.31036295 |
| 30 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.26217829 |
| 31 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19505930 |
| 32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.19482987 |
| 33 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.17013859 |
| 34 | Cell cycle_Homo sapiens_hsa04110 | 1.12599698 |
| 35 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.08312219 |
| 36 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.04844921 |
| 37 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.03581730 |
| 38 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.02740282 |
| 39 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.01315010 |
| 40 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.01267153 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99942066 |
| 42 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.95120998 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.94918795 |
| 44 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.92313109 |
| 45 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.89726409 |
| 46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.87559472 |
| 47 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.86984434 |
| 48 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.86660925 |
| 49 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.82308144 |
| 50 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.81324098 |
| 51 | Basal transcription factors_Homo sapiens_hsa03022 | 0.78969655 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.78785197 |
| 53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.77902510 |
| 54 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.76748560 |
| 55 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.76573351 |
| 56 | RNA degradation_Homo sapiens_hsa03018 | 0.75287109 |
| 57 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.72797409 |
| 58 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70452691 |
| 59 | * Purine metabolism_Homo sapiens_hsa00230 | 0.69928761 |
| 60 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.69076963 |
| 61 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66409330 |
| 62 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.65060282 |
| 63 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.63878397 |
| 64 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.63425544 |
| 65 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.62703236 |
| 66 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.57758792 |
| 67 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.56495202 |
| 68 | Peroxisome_Homo sapiens_hsa04146 | 0.56383230 |
| 69 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.55246359 |
| 70 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.54944431 |
| 71 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.54907030 |
| 72 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.53750857 |
| 73 | Legionellosis_Homo sapiens_hsa05134 | 0.51705111 |
| 74 | Bladder cancer_Homo sapiens_hsa05219 | 0.51341619 |
| 75 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.50588688 |
| 76 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.50582175 |
| 77 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.49372342 |
| 78 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.46834605 |
| 79 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.46314534 |
| 80 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.45492230 |
| 81 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.44991934 |
| 82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44352202 |
| 83 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.43688224 |
| 84 | Viral myocarditis_Homo sapiens_hsa05416 | 0.42531119 |
| 85 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42417818 |
| 86 | Other glycan degradation_Homo sapiens_hsa00511 | 0.41750640 |
| 87 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.40573325 |
| 88 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.40560442 |
| 89 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.40518993 |
| 90 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.39612114 |
| 91 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38029974 |
| 92 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.37879148 |
| 93 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.36165301 |
| 94 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.35691378 |
| 95 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.35290138 |
| 96 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.33008764 |
| 97 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.32279490 |
| 98 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.32089726 |
| 99 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.31600675 |
| 100 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.31211508 |
| 101 | HTLV-I infection_Homo sapiens_hsa05166 | 0.30916007 |
| 102 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.30651697 |
| 103 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.30395452 |
| 104 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29885476 |
| 105 | Thyroid cancer_Homo sapiens_hsa05216 | 0.29738640 |
| 106 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.29305895 |
| 107 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.29296102 |
| 108 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.29189968 |
| 109 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.28921354 |
| 110 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.28146261 |
| 111 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.27547601 |
| 112 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.23186680 |
| 113 | Melanoma_Homo sapiens_hsa05218 | 0.22430710 |
| 114 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.19922066 |
| 115 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.19440981 |
| 116 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.18766624 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.18632308 |
| 118 | Apoptosis_Homo sapiens_hsa04210 | 0.17319711 |
| 119 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.17268816 |
| 120 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.17240522 |
| 121 | Lysine degradation_Homo sapiens_hsa00310 | 0.17064348 |
| 122 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.16977382 |
| 123 | Shigellosis_Homo sapiens_hsa05131 | 0.15165494 |
| 124 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.14831326 |
| 125 | Alcoholism_Homo sapiens_hsa05034 | 0.14046576 |
| 126 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.13377960 |

